Tevogen Bio (TVGN) News Today $0.84 -0.01 (-1.18%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$0.86 +0.02 (+2.86%) As of 06:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TVGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in BostonSeptember 10, 2025 | globenewswire.comTevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B InfectionSeptember 9, 2025 | globenewswire.comTevogen Bio Inc: Tevogen Values TVGN-489 at $9-$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell Allogeneic T Cell PlatformSeptember 9, 2025 | finanznachrichten.deTevogen values TVGN-480 at $9B-$11B rNPVSeptember 9, 2025 | msn.comTevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell PlatformSeptember 8, 2025 | globenewswire.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest UpdateSeptember 8, 2025 | marketbeat.comTevogen Bio's (TVGN) "Buy" Rating Reiterated at D. Boral CapitalSeptember 7, 2025 | americanbankingnews.comTevogen Bio's (TVGN) "Buy" Rating Reaffirmed at D. Boral CapitalSeptember 6, 2025 | marketbeat.comTevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and LymphomasSeptember 4, 2025 | globenewswire.comTevogen Bio Highlights Promising Clinical Results for TVGN 489 in Treating SARS-CoV-2 in Immunocompromised PatientsSeptember 3, 2025 | quiverquant.comQTevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2September 3, 2025 | globenewswire.comTevogen Bio Inc: Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation DisclosureAugust 28, 2025 | finanznachrichten.deTevogen Bio Holdings Inc. Highlights Internally Developed Assets Reflecting Long-Term ValueAugust 27, 2025 | quiverquant.comQTevogen Bio Highlights Proprietary Assets and Upcoming Valuation DisclosureAugust 27, 2025 | globenewswire.comTevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health EquityAugust 26, 2025 | markets.businessinsider.comTevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company's Mission of Health EquityAugust 26, 2025 | globenewswire.comTevogen Bio Holdings Inc. Reports 24% Increase in Institutional Ownership in Q2 2025August 25, 2025 | quiverquant.comQTevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained PositionsAugust 25, 2025 | globenewswire.comTevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable BiopharmaAugust 22, 2025 | markets.businessinsider.comTevogen Bio Holdings Inc. Recognized in BINJE's BEST Health Care 2025 for Commitment to Health Equity and InnovationAugust 22, 2025 | quiverquant.comQTevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable BiopharmaAugust 22, 2025 | globenewswire.comTevogen Bio (NASDAQ:TVGN) Announces Earnings ResultsAugust 21, 2025 | marketbeat.comD. Boral Capital Reiterates Buy Rating for Tevogen Bio (NASDAQ:TVGN)August 20, 2025 | marketbeat.comTevogen finalizes agreement for up to $50M in financingAugust 19, 2025 | msn.comREPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development EffortsAugust 19, 2025 | globenewswire.comTevogen Bio Holdings Inc. Reports Q2 2025 Financial Results with Reduced Loss from Operations and Focus on Growth StrategyAugust 19, 2025 | quiverquant.comQTevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth MomentumAugust 19, 2025 | globenewswire.comTevogen CEO Donates Personal Shares to Support Local Law EnforcementAugust 18, 2025 | globenewswire.comTevogen CEO Donates Personal Shares to Support Brain Injury RecoveryAugust 18, 2025 | globenewswire.comSemper Paratus Acquisition (NASDAQ:TVGN) Stock Price Down 3% - Here's What HappenedAugust 16, 2025 | marketbeat.comTevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully ProtectedAugust 14, 2025 | globenewswire.comRepeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on OncologyAugust 13, 2025 | globenewswire.comTevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 BillionAugust 11, 2025 | globenewswire.comREPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 BillionAugust 11, 2025 | globenewswire.comTevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to FollowAugust 11, 2025 | globenewswire.comREPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to StockholdersAugust 11, 2025 | globenewswire.comREPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase PositionsAugust 8, 2025 | globenewswire.comTevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth StrategyAugust 7, 2025 | globenewswire.comTevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase PositionsAugust 6, 2025 | globenewswire.comTevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on OncologyAugust 5, 2025 | globenewswire.comSemper Paratus Acquisition (NASDAQ:TVGN) Given Buy Rating at D. Boral CapitalAugust 5, 2025 | marketbeat.comSemper Paratus Acquisition Corporation (NASDAQ:TVGN) Sees Significant Increase in Short InterestAugust 2, 2025 | marketbeat.comTevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to StockholdersAugust 1, 2025 | globenewswire.comTevogen Bio to Accept $1 Million Additional Grant Funding for AI ExpansionAugust 1, 2025 | globenewswire.comTevogen Highlights 74% Insider Ownership, Reinforcing Long-Term VisionJuly 30, 2025 | globenewswire.comTevogen.AI Applauds U.S. Government's AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in HealthcareJuly 28, 2025 | globenewswire.comSemper Paratus Acquisition (NASDAQ:TVGN) Shares Down 2.7% - Should You Sell?July 24, 2025 | marketbeat.comTevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active PeptidesJuly 18, 2025 | globenewswire.comTevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing FacilityJuly 17, 2025 | globenewswire.comTevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha LaunchJuly 16, 2025 | globenewswire.com Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TVGN Media Mentions By Week TVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼0.950.92▲Average Medical News Sentiment TVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼04▲TVGN Articles Average Week Get the Latest News and Ratings for TVGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tevogen Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Tyra Biosciences News Today Gossamer Bio News Today ProKidney News Today Ginkgo Bioworks News Today Bicara Therapeutics News Today SNDL News Today Septerna News Today Savara News Today Maravai LifeSciences News Today Organogenesis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVGN Stock Alerts